Sam Altman’s Brain Chip Venture Is Mulling Gene Therapy Approach
Summary Sam Altman’s brain-computer interface venture — reported as Merge Labs — is exploring a gene-therapy route that would genetically modify brain cells to respond to ultrasound, combined with an…
